Molecular subtyping of mammary‐like adenocarcinoma of the vulva shows molecular similarity to breast carcinomas
- 16 June 2017
- journal article
- Published by Wiley in Histopathology
- Vol. 71 (3) , 446-452
Abstract
Aims: Mammary‐like adenocarcinoma (MLA) of the vulva is thought to be derived from vulvar mammary‐like glands. The aim of this study was to characterize a series of MLAs by using an immunohistochemical algorithm that identifies the major molecular subtypes of breast cancer.Methods and results: Seven cases of vulval MLA were stained for oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), Ki67, epidermal growth factor receptor (EGFR), cytokeratin (CK) 5, nestin, and inositol polyphosphate‐4‐phosphatase (INPP4b). Seventeen cases of vulval extramammary Paget disease (EMPD), seven with invasion, were studied for comparison. The median age of patients with MLA was 72 years. All tumours except one were early‐stage tumours. On the basis of an immunohistochemical panel, three of seven tumours were classified as luminal B, two of seven as HER2‐enriched, one of seven as luminal A, and one of seven as basal‐like. ER was expressed in four of seven tumours, PR in three of seven, HER2 in three of seven, EGFR in two of seven, and CK5 in one of seven, and the Ki67 index was >15% in six of seven cases. Nestin and INPP4b were, respectively, negative and positive in all cases. Of the seven cases of invasive EMPD, two showed a luminal A profile, three a luminal B profile (two of three with HER2 amplification), one a HER2‐enriched profile, and one a basal‐like profile. Three of seven were HER2‐amplified. Among the 10 cases of EMPD without invasion, seven showed a luminal A profile and three showed a luminal B profile (all HER2‐amplified); no HER2‐enriched or basal‐like subtypes were identified.Conclusions: Breast cancer subtyping can be applied to vulvar MLAs. All four intrinsic molecular subtypes are seen, with frequencies similar to those in breast carcinoma. Our results support the potential use of breast cancer molecular profiling algorithms to guide treatment for these cancers.Keywords
This publication has 37 references indexed in Scilit:
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Phosphoinositide 3‐kinase and INPP4B in human breast cancerAnnals of the New York Academy of Sciences, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Gene expression profiling guiding diagnosis and therapy of rare mammary-like anogenital gland carcinomasMedical Oncology, 2010
- Breast Cancer Subtypes and the Risk of Local and Regional RelapseJournal of Clinical Oncology, 2010
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI: Journal of the National Cancer Institute, 2009
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative PhenotypeClinical Cancer Research, 2008
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- Mammary-like Glands of the Vulva and Their DisordersInternational Journal of Gynecological Pathology, 1994